Enliang Li

发表

A novel prognostic model for diagnosing atypical bile duct hyperplasia in patients with intrahepatic lithiasis

Hongcheng Lu, Hao Yang, Linquan Wu, 2019, Medicine.

The diagnostic value of assays for circulating tumor cells in hepatocellular carcinoma

Y. Mao, J. Shao, Linquan Wu, 2017, Medicine.

Rare anatomic variation of the right hepatic artery and accessory right hepatic artery supplying hepatocellular carcinoma

Linquan Wu, Enliang Li, Chengwu Gong, 2017, Medicine.

Overexpression of non-SMC condensin I complex subunit G serves as a promising prognostic marker and therapeutic target for hepatocellular carcinoma

Fan Zhou, Xin Yu, Linquan Wu, 2017, International journal of molecular medicine.

TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a

Linquan Wu, Wen-jun Liao, Enliang Li, 2021, Journal of Cancer.

TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a

Wen-jun Liao, Enliang Li, Qian Feng, 2020, Journal of Cancer.

Liver Transplantation for Alcohol-Related Liver Disease (ARLD): An Update on Controversies and Considerations

Qi Zhang, T. Liang, X. Bai, 2020, Canadian journal of gastroenterology & hepatology.

Metabolic signatures of hepatolithiasis using ultra-high performance liquid chromatography-tandem mass spectrometry

Fan Zhou, Linquan Wu, Enliang Li, 2022, Metabolomics.

TP53 mutation detected in circulating exosomal DNA is associated with prognosis of patients with hepatocellular carcinoma

Y. Mao, Fan Zhou, Linquan Wu, 2022, Cancer biology & therapy.

IFITM3 Regulates NCAPG Through Phosphorylation to Influence the Invasion and Metastasis of HCC

Linquan Wu, Enliang Li, Weiwei Liu, 2020 .

Comprehensive analysis of the effects of KIF2C on prognosis, biological functions and immune infiltration in PAAD.

J. Xiong, Linquan Wu, Enliang Li, 2022, Tissue & cell.

Circular RNA MYLK Promotes Hepatocellular Carcinoma Progression Through the miR29a/KMT5C Signaling Pathway

Linquan Wu, Enliang Li, Jun Gao, 2020, OncoTargets and therapy.

Galectin-9 and PD-L1 antibody blockade combination therapy inhibits tumour progression in pancreatic cancer.

Xiaozhen Zhang, Qi Chen, T. Liang, 2023, Immunotherapy.

Combinational blockade of MET and PD-L1 improves pancreatic cancer immunotherapeutic efficacy

Xing Huang, T. Liang, Enliang Li, 2021, Journal of experimental & clinical cancer research : CR.

The AKT-independent MET–V-ATPase–MTOR axis suppresses liver cancer vaccination

Xing Huang, Xiaozhen Zhang, T. Liang, 2020, Signal Transduction and Targeted Therapy.

NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1

Xing Huang, Xiaozhen Zhang, T. Liang, 2021, Nature Communications.

Targeting the HGF/MET Axis in Cancer Therapy: Challenges in Resistance and Opportunities for Improvement

Xing Huang, Xiaozhen Zhang, T. Liang, 2020, Frontiers in Cell and Developmental Biology.

Pancreatic adenosquamous carcinoma: A population level analysis of epidemiological trends and prognosis

Linquan Wu, Enliang Li, Min Li, 2023, Cancer medicine.

TUG1 as ceRNA combined with miR-29a to promotes the expression of IFITM3 in hepatocellular carcinoma

Linquan Wu, Enliang Li, Jun Gao, 2020 .

miR-29a suppresses the growth and metastasis of hepatocellular carcinoma through IFITM3

Linquan Wu, Enliang Li, Chengwu Gong, 2018, Oncology reports.

VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy

Xing Huang, Xiaozhen Zhang, T. Liang, 2020, Journal of Hematology & Oncology.

Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends

Hao Yang, Linquan Wu, Enliang Li, 2019, World Journal of Surgical Oncology.

Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients

T. Liang, Enliang Li, Yuan Yang, 2022, Journal of translational medicine.

Robotic versus open extended cholecystectomy for T1a–T3 gallbladder cancer: A matched comparison

Linquan Wu, Enliang Li, Jun Yang, 2022, Frontiers in Surgery.

IFITM3 promotes hepatocellular carcinoma invasion and metastasis by regulating MMP9 through p38/MAPK signaling

Linquan Wu, Enliang Li, Chengwu Gong, 2018, FEBS open bio.

Epidemiological trends for functional pancreatic neuroendocrine tumors: A study combining multiple imputation with age adjustment

Fan Zhou, Linquan Wu, Enliang Li, 2023, Frontiers in Endocrinology.

Robotic approach together with an enhanced recovery programme improve the perioperative outcomes for complex hepatectomy

Linquan Wu, Enliang Li, J. Lei, 2023, Frontiers in Surgery.

Based on the IWATE criteria: to investigate the influence of different surgical approaches on the perioperative outcomes of hepatectomy

Linquan Wu, Enliang Li, J. Lei, 2022, Surgical Endoscopy.

Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality

Linquan Wu, Enliang Li, Chi Sun, 2019, BMC Cancer.

Validation of a supplementary condition of eighth AJCC staging system for stage II hepatocellular carcinoma.

Fan Zhou, Linquan Wu, Enliang Li, 2023, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Application of VR and 3D printing in liver reconstruction

Linquan Wu, Enliang Li, Wenjun Liao, 2022, Annals of translational medicine.

Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality

Linquan Wu, Enliang Li, Chi Sun, 2019, BMC Cancer.

LncTUG1 promotes hepatocellular carcinoma immune evasion via upregulating PD-L1 expression

Linquan Wu, Enliang Li, Qingping Yang, 2023, Scientific reports.

Validation of the Prognostic Role for Surgical Treatment in Stage II Intrahepatic Cholangiocarcinoma: A SEER Population-Based Study

Fan Zhou, Linquan Wu, Enliang Li, 2023, Journal of clinical medicine.

Circular RNA MYLK Promotes Hepatocellular Carcinoma Progression Through the miR29a/ KMT5C Signaling Pathway

Enliang Li, Jiyuan Ai, Jun Gao, 2020 .